Identification of Potential Therapeutics of Mentha Essential Oil Content as Antibacterial MDR Agents against AcrAB-TolC Multidrug Efflux Pump from Escherichia coli: An In Silico Exploration

被引:1
|
作者
Alenazy, Rawaf [1 ]
机构
[1] Shaqra Univ, Coll Appl Med Sci Shaqra, Dept Med Lab, Shaqra 11961, Saudi Arabia
来源
LIFE-BASEL | 2024年 / 14卷 / 05期
关键词
Mentha; essential oils; antimicrobial MDR; E. coli AcrB-TolC; in silico molecular docking; CHEMICAL-COMPOSITION; ANTIOXIDANT ACTIVITIES; LONGIFOLIA L; RESISTANCE; PULEGIUM;
D O I
10.3390/life14050610
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multidrug-resistant bacterial pathogens, such as E. coli, represent a major human health threat. Due to the critical need to overcome this dilemma, since the drug efflux pump has a vital function in the evolution of antimicrobial resistance in bacteria, we have investigated the potential of Mentha essential oil major constituents (1-19) as antimicrobial agents via their ability to inhibit pathogenic DNA gyrase and, in addition, their potential inhibition of the E. coli AcrB-TolC efflux pump, a potential target to inhibit MDR pathogens. The ligand docking approach was conducted to analyze the binding interactions of Mentha EO constituents with the target receptors. The obtained results proved their antimicrobial activity through the inhibition of DNA gyrase (1kzn) with binding affinity Delta G values between -4.94 and -6.49 kcal/mol. Moreover, Mentha EO constituents demonstrated their activity against MDR E. coli by their ability to inhibit AcrB-TolC (4dx7) with Delta G values ranging between -4.69 and -6.39 kcal/mol. The antimicrobial and MDR activity of Mentha EOs was supported via hydrogen bonding and hydrophobic interactions with the key amino acid residues at the binding site of the active pocket of the targeted receptors.
引用
收藏
页数:13
相关论文
共 20 条
  • [1] Synthesis of novel efflux pump inhibitors which target the AcrAB-TolC multidrug efflux system in Escherichia coli
    Haynes, Keith
    Abdali, Narges
    Parks, Jerry
    Chaney, Julie
    Green, Adam
    Wolloscheck, David
    Walker, John
    Wood, Natalie
    Rybenkov, Valentine
    Baudry, Jerome
    Smith, Jeremy
    Zgurskaya, Helen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [2] Sodium Malonate Inhibits the AcrAB-TolC Multidrug Efflux Pump of Escherichia coli and Increases Antibiotic Efficacy
    Cauilan, Allea
    Ruiz, Cristian
    PATHOGENS, 2022, 11 (12):
  • [3] Global effect of the AcrAB-TolC multidrug efflux pump of Escherichia coli in cell metabolism revealed by untargeted metabolomics
    Cauilan, Allea
    Ramos, Karen
    Harmon, Dana E.
    Ruiz, Cristian
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (01) : 105 - 107
  • [4] The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach
    Abdel-Halim, Heba
    Al Dajani, Ala'a
    Abdelhalim, Abeer
    Abdelmalek, Suzanne
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (15) : 6309 - 6318
  • [5] Required criteria of drug efflux pump inhibitors to disrupt the function of AcrB subunit protein from AcrAB-TolC multidrug efflux pump from Escherichia coli
    Alenazy, Rawaf
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2024, 36 (04)
  • [6] Artesunate enhances the antibacterial effect of β-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC
    Li, Bin
    Yao, Qi
    Pan, Xi-Chun
    Wang, Ning
    Zhang, Rong
    Li, Jun
    Ding, Guofu
    Liu, Xin
    Wu, Chong
    Ran, Dongzhi
    Zheng, Jiang
    Zhou, Hong
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) : 769 - 777
  • [7] Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli
    Wan, Xiulin
    Li, Qingyang
    Olsen, Rikke Heidemann
    Meng, Hecheng
    Zhang, Zhigang
    Wang, Junlin
    Zheng, Hanyu
    Li, Lili
    Shi, Lei
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (08) : 2158 - 2166
  • [8] Expression of Multidrug Efflux Pump Genes acrAB-tolC, mdfA, and norE in Escherichia coli Clinical Isolates as a Function of Fluoroquinolone and Multidrug Resistance
    Swick, Michelle C.
    Morgan-Linnell, Sonia K.
    Carlson, Kimberly M.
    Zechiedrich, Lynn
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) : 921 - 924
  • [9] Assembly and mechanism of the Type I multi-drug efflux pump AcrAB-TolC from Escherichia coli
    Bokma, E.
    Lobedanz, S.
    Symmons, M. F.
    Koronakis, E.
    Brandstatter, H.
    Koronakis, V.
    Hughes, C.
    AMINO ACIDS, 2007, 33 (03) : VIII - IX
  • [10] Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia coli
    Alenazy, Rawaf
    BIOLOGY-BASEL, 2022, 11 (09):